Target Price | $18.75 |
Price | $2.64 |
Potential |
610.23%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Inozyme Pharma Inc 2025 .
The average Inozyme Pharma Inc target price is $18.75.
This is
610.23%
register free of charge
$43.00
1,528.79%
register free of charge
$12.00
354.55%
register free of charge
|
|
A rating was issued by 9 analysts: 9 Analysts recommend Inozyme Pharma Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Inozyme Pharma Inc stock has an average upside potential 2025 of
610.23%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.37 | -1.60 |
23.03% | 16.79% | |
P/E | negative |
9 Analysts have issued a Inozyme Pharma Inc forecast for earnings per share. The average Inozyme Pharma Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Inozyme Pharma Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.